A detailed history of Logos Global Management LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 1,200,000 shares of RVMD stock, worth $72.7 Million. This represents 4.37% of its overall portfolio holdings.

Number of Shares
1,200,000
Previous 1,200,000 -0.0%
Holding current value
$72.7 Million
Previous $46.6 Million -0.0%
% of portfolio
4.37%
Previous 4.37%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$30.14 - $40.68 $36.2 Million - $48.8 Million
1,200,000 New
1,200,000 $46.6 Million
Q4 2023

Feb 14, 2024

BUY
$18.35 - $34.12 $1.84 Million - $3.41 Million
100,000 Added 40.0%
350,000 $10 Million
Q3 2023

Nov 14, 2023

BUY
$25.17 - $35.05 $6.29 Million - $8.76 Million
250,000 New
250,000 $6.92 Million
Q2 2020

Aug 14, 2020

SELL
$19.65 - $39.34 $1.04 Million - $2.09 Million
-53,034 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$20.0 - $34.08 $1.06 Million - $1.81 Million
53,034 New
53,034 $1.16 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $5.31B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.